Resources

Company Documents

Offering, financial, regulatory and clinical documents provided by Lionheart Health, Inc. for prospective and current investors.

Offering

Private Placement Memorandum
Dated September 18, 2026. Up to $3,000,000 of common stock under Rule 506(c).
PDF · 28 pages
View PDF
Blue Sky Investor List
PDF · 1 page
View PDF

Financial

Unit Gross Margins
Board reference, September 23, 2026.
PDF · 1 page
View PDF

Regulatory & Clinical

Clinical Data Summary
Updated November 2026. Reported clinical, pilot, observational and preliminary laboratory results.
PDF · 4 pages
View PDF
FDA 510(k) K113017: 240 Stimulator
PDF · 8 pages
View PDF
FDA 510(k) K181955: Wiemspro EMS Suit (BodStim)
PDF · 11 pages
View PDF
Regulatory 510(k)s and More
PDF · 4 pages
View PDF
IRB Approval: Klotho Wellness Study (LL-KW-001)
March 23, 2026.
PDF · 1 page
View PDF
IRB Submission Packet: Klotho Wellness Study
November 30, 2025.
PDF · 41 pages
View PDF
Investigators List
PDF · 25 pages
View PDF
Regulatory Compliance Dashboard
Updated February 1, 2026.
PDF · 24 pages
View PDF
Regulatory Compliance SOPs
January 15, 2026.
PDF · 25 pages
View PDF
SOP for Data Management
March 1, 2026.
PDF · 14 pages
View PDF

Data room

The full capitalization table, which includes shareholder contact details, is kept in the company’s password-protected data room.

Get Data Room Access

This website is not an offer to sell or a solicitation of an offer to buy securities. Any offer is made only through the Private Placement Memorandum, to verified accredited investors under Rule 506(c) of Regulation D. Questions about these documents can be sent tocs@lionheartlongevity.com.